Frédéric Desdouits, TreeFrog Therapeutics CEO
September 13, 2021 10:58 AM EDTUpdated September 16, 12:27 PM
Financing
Cell/Gene Tx

French biotech rais­es $75M for new cell ther­a­py man­u­fac­tur­ing tech, Parkin­son's treat­ment

Josh Sullivan

A French cell ther­a­py start­up is get­ting two new of­fices in op­po­site parts of the world, and a new CEO to boot as it an­nounces …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times